Search
for
Sort by
Research 91–120 of 1000+
- Food and medicine homology: a potential nutritional intervention strategy for post-acute COVID-19 syndrome
- Pharmacological Strategies for Mitigating Cytarabine-Induced Multi-Organ Toxicity: A Scoping Review on Mechanisms, Efficacy and Clinical Implications
- Low-Dose Oral Minoxidil Beyond Androgenetic Alopecia: A Comparative Narrative Review of Emerging Evidence
- Focused Review on Metal Nanoparticles in Hair Regeneration and Alopecia: Insights into Mechanisms, Assessment Techniques, Toxicity, Regulatory and Intellectual Property Perspectives
- Management of Dermatologic Toxicities
- Clinical and genetic predictors of persistent chemotherapy-induced alopecia despite scalp cooling in breast cancer
- Mitoxantrone, Etoposide and Prednisolone—a Novel Combination in The Treatment of Relapsed and Refractory Lymphoma
- [Protective effects of coenzyme Q10 on the adverse reactions of anthracycline antibiotics: using double blind method--with special reference to hair loss].
- Efficacy of Scalp Cooling in the Prevention of Chemotherapy Induced Alopecia Among Breast Cancer Patients
- Results of scalp cooling during anthracycline containing chemotherapy depend on scalp skin temperature
- Calreticulin: non‐endoplasmic reticulum functions in physiology and disease
- SARS-CoV-2 Non-Structural Proteins and Their Roles in Host Immune Evasion
- Safety and efficacy of low-dose metronomic cyclophosphamide plus vinorelbine in patients with metastatic breast cancer previously treated with anthracyclines and taxanes.
- Stimuli-responsive nanoformulations for CRISPR-Cas9 genome editing
- Approach to the patient with hair loss
- The role of WNT10B in physiology and disease: A 10-year update
- Drug Repurposing against KRAS Mutant G12C: A Machine Learning, Molecular Docking, and Molecular Dynamics Study
- Mitoxantrone
- Drug Treatment of Acute Leukaemia Current Status
- Alopecia/hair loss in all patients treated with trastuzumab and paclitaxel: myth or reality?
- Impact of Reporter Type on Signal Detection of Cancer Therapy–Induced Alopecia: A Hypothesis-Generating Study Using the FDA Adverse Event Reporting System
- Clinical Development of Topoisomerase-Interactive Drugs
- Hétérogénéité tumorale du cancer de la prostate et infection par le SARS-CoV2 : une relation complexe impliquant les vésicules extracellulaires et le récepteur des androgènes
- Drug-Induced Skin, Nail and Hair Disorders
- Premature Hair Graying: Underlying Contributors and Management Approaches - An Updated Literature Review
- Molecular targeted therapies for cancer: Sorafenib mono�therapy and its combination with other therapies (Review)
- Cutaneous complications of chemotherapeutic agents
- Adverse effects of common medications on male fertility
- Chemotherapy-Induced Hair Loss: The Use of Biomarkers for Predicting Alopecic Severity and Treatment Efficacy
- Trends in Nanotechnology for Practical Applications